Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000498209 | SCV000590609 | uncertain significance | not provided | 2023-11-20 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Labcorp Genetics |
RCV000498209 | SCV003515090 | benign | not provided | 2024-01-05 | criteria provided, single submitter | clinical testing | |
Institute of Human Genetics, |
RCV003222005 | SCV003915943 | uncertain significance | Hearing loss, autosomal dominant 37 | 2023-04-18 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004023347 | SCV004926769 | uncertain significance | Inborn genetic diseases | 2023-11-06 | criteria provided, single submitter | clinical testing | The c.4661C>T (p.T1554M) alteration is located in exon 63 (coding exon 63) of the COL11A1 gene. This alteration results from a C to T substitution at nucleotide position 4661, causing the threonine (T) at amino acid position 1554 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |